Get more information on Artificial Intelligence In Genomics Market - Request Sample Report
The Artificial Intelligence in Genomics Market Size was valued at USD 699.7 million in 2023 and is expected to reach USD 19018.4 million by 2032 and grow at a CAGR of 44.3% over the forecast period 2024-2032.
The AI revolution is changing the genomics market by integrating it into the healthcare sphere, which finds impetus based on increased demand for tailored medicines and R&D spending. The AI in the genomics market is experiencing spectacular growth. This growth can primarily be attributed to revolutionary advancements in AI technologies and the cost-effectiveness of such technologies.o
Machine learning and deep learning algorithms have advanced significantly in the analysis of genomic data. Advanced tools enable researchers to notice patterns or interconnected patterns that could not be detected by natural methods. AI-based solutions allow for faster efficiency and reduce the cost of operations by automating most tasks related to genomic research. For example, during the COVID-19 pandemic, companies such as NVIDIA designed innovative genomics sequencing tools. Using these tools, researchers could track and analyze COVID-19 variants more effectively. It coordinated the efforts of the interested parties in the health sector to rush through the production of vaccines and drugs to curb acute health problems and expounds upon AI's contribution toward the effort.
AI-generated models of the human body significantly make new drugs safer and more effective. It now allows for more precise diagnoses that can lead to the development of proper treatment courses. One of the most groundbreaking developments recently designed is AI tools that can predict the outcome of genome-editing repair strategies without errors in treatments used for genetic diseases. These developments enhance not only the accuracy of genetic interventions but also the use of AI technology in clinical settings. The rise of prime editing, the latest genome editing revolution, is one instance of further synergy between AI and genomics in transforming the treatment of genetic disorders and propelling personalized medicine. In general, the growth of AI within the Genomics market signals a transformational shift in healthcare in which data-driven insights guide therapeutics to effectively tailor medical treatment and enrich patient care.
| Application Area | Description | Impact on AI in Genomics |
|---|---|---|
| Genomic Data Interpretation | Analyzing vast genomic datasets to identify mutations. | Accelerates understanding of genetic diseases |
| Drug Discovery | Using AI to predict drug interactions with genetic profiles. | Reduces time and cost of new drug development |
| Precision Medicine | Tailoring treatments based on individual genetic makeup. | Improves treatment efficacy and patient outcomes |
| Genomic Diagnostics | Enhancing the accuracy of genetic tests through AI algorithms. | This leads to earlier and more accurate disease detection. |
| Population Genomics | Analyzing genetic variations across populations. | Informs public health strategies and personalized care |
| Trend | Description | Potential Impact |
|---|---|---|
| Increased Automation | More automated processes in genomic data analysis. | Enhances efficiency and reduces human error |
| Enhanced Data Sharing | Improved platforms for sharing genomic data across institutions. | Promotes collaboration and accelerates research |
| AI-Driven Research | AI becoming integral in genomic research methodologies. | Fosters innovation and discovery in genetics |
| Integration of Multi-Omics Data | Combining genomic data with proteomic and metabolomic data. | Provides a holistic view of biological systems |
| Real-Time Genomic Analysis | Advancements enabling real-time analysis of genomic data. | Facilitates immediate clinical decision-making |
DRIVERS
Pioneering Advances in Data Management and Drug Development
The unprecedented surges in the generation of genomic data, estimated to be wide-ranging from 2 to 40 billion gigabytes annually in biomedical research and large-scale collaborations, are causing rapid growth. This increase in genomic data is mainly the reason genomics needs artificial intelligence today. For example, now that AI technologies like machine learning and deep learning algorithms are used to better manage and analyze enormous datasets, it has opened up avenues for extracting valuable insights in genomics and accelerating discoveries. Given the boom of biomedical and genomic data, scientists are now in the process of developing useful AI algorithms for processing complex data patterns and inferring relationships buried within DNA sequences. Such sophisticated solutions present a lot of promise, but several challenges still linger in this case, related to the inner workings of AI algorithms that might introduce biases into the analysis of DNA data.
Further, the rising adoption of AI-based solutions also supports the growing market. AI is moving very fast at identifying genetic mutations in tumors by employing high-resolution 3D imaging techniques. Today, some latest technologies have emerged with the capacity to detect glioma-type tumors from scans taken directly from the brain without needing an invasive biopsy to reduce the risk involved in the surgery. The diagnosis is made automatically through AI and machine learning which is revolutionizing the health sector and finds support in the digitization of health-related data and swift technological advancements.
There is also the pressure of rising costs of R&D that squeeze the profit margins of the pharmaceutical industry. As companies seek to revolutionize these areas, one of the exciting spaces where AI can make a difference is in drug discovery. According to Bloomberg, AI can improve timelines up to two or three times the speed of traditional methods, create a dramatically better cost structure, and increase the chances of approval. Many of them are significant companies, such as Johnson & Johnson, AstraZeneca, and Pfizer, that have undertaken substantial efforts to integrate AI with genomics and engineering tools towards better target identification and validation. For example, the knowledge graphs and image analysis applied in AstraZeneca will derive insights on diseases and classify biomarkers 30% faster than traditional processes. Other relevant collaborations are those carried out between industry firms and AI specialists, like Renalytix AI, which showcases the commitment of the pharmaceutical industry to innovation in drug discovery.
The increasing investments from pharmaceutical companies in drug discovery and development activities are expected to drive the growth of AI in genomics. Moreover, since these processes tend to be highly costly, embracing AI technologies will most likely improve operational efficiency and quality, thus saving costs. So, an increased amount of chronic and infectious diseases have been increasing demand from pharmaceutical companies as well as stimulating huge investment in drug discovery and development, which will eventually augment the growth of global AI in the genomics market.
RESTRAINTS
Unclear Regulatory Framework for Genomics Software
Shortage of Skilled Workforce and Infrastructure
By Component
services. In 2023, the major share of the market was accounted for by the software component, holding an approximate 40% share, and is further projected to gain the highest compound annual growth rate, 46.6%, in the forecast period. The growth is mainly due to the adoption of AI-based software solutions in healthcare institutions and research and development centers.
Artificial intelligence technology has already been integrated into several healthcare applications, such as cybersecurity, clinical trials, virtual assistants, telemedicine, and fraud detection, amongst others, thus propelling the rapid growth of this segment. In addition to tBIOhis, public as well as private sector initiatives are highly driving ahead the market growth. For instance, in July 2018, Illumina, Inc. released open-source AI software that would differentiate between disease-causing mutations and the millions of benign genetic variants that exist in individuals.
Need any customization research on Artificial Intelligence In Genomics Market - Enquiry Now
By Technology
Technology is further segmented into machine learning and computer vision. In 2023, the share of the machine learning segment accounted for about 63% and is anticipated to witness the highest compound annual growth rate during the forecast period. There are a few ways machine learning helps in genomic research as scientists need to make discoveries and advance knowledge related to the genetics of health and disease. Algorithms can automate labor-intensive time-consuming work like annotating genomic data and finding potential drug targets to improve efficiency.
On the other hand, the computer vision segment is expected to gain a significant CAGR of more than 45% during the forecast period. Computer vision refers to algorithms that are used for analyzing and interpreting images, which has been gaining ground in genomics applications. With automated processes and outcomes more accurate, computer vision is bound to play an important role in furthering genomics research.
North America dominated the global AI in the genomics market in 2023, holding around 29.0% of the revenue share. The reason for this massive share is significant among all other factors. This is because North America is home to the presence of several major players involved in this market, such as Danone, Abbott, Nestlé, Targeted Medical Pharma, Inc., and Mead Johnson & Company, LLC. Market Share is also expected to be dominated by North America, as it houses the largest and most well-endowed research institutes and biotechnology companies worldwide, that are highly investing in developing AI-driven solutions for genomics. The wave of investments is fostering innovative software and tools for genomic data analytics and driving the development of the AI in genomics market in this region.
The Asia Pacific region is expected to grow the fastest with a CAGR of 47.1% during the forecast period. It is driven by multiple factors such as rapidly escalating healthcare expenses, an increased focus on precision medicine, improved genomics technology, and a large and increasing population base. Many Asian countries have embarked on national genomics programs to establish genetic databases of the population through the sequencing of the DNA of healthy individuals. For example, in 2019, the Thai government entered into a five-year Genomics Initiative worth USD 150 million to characterize the genomes of 50,000 citizens. As such, this strategic focus is highly likely to push demand for AI in genomics within the Asia Pacific region very significantly.
AI Platforms and Software
Microsoft Corporation
Genomic Data Analysis and Interpretation
Data4Cure, Inc.
Freenome Holdings, Inc.
Genomic Sequencing and Tools
Thermo Fisher Scientific
Illumina, Inc.
Genomic Data Integration and Interpretation
SOPHiA GENETICS
BenevolentAI
Fabric Genomics
In May 2024, the AI-driven EXPRESSO model was developed to predict the risk of autoimmune diseases by analyzing genomic data, epigenetics, and other relevant information, enabling the identification of specific risk genes associated with these conditions.
In February 2023, Accenture Ventures announced a strategic investment in Ocean Genomics, a technology and AI firm that has created advanced computational platforms aimed at helping biopharma companies enhance the discovery and development of more effective diagnostics and therapeutics.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 699.7 million |
| Market Size by 2032 | US$ 19018.4 million |
| CAGR | CAGR of 44.3% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Component (Hardware, Software, Services) • By Technology [Machine Learning (Deep Learning, Supervised Learning, Unsupervised Learning, Others), Computer Vision] • By Functionality (Genome Sequencing, Gene Editing, Others) • By Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Others) • By End-use (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | IBM, Microsoft Corporation, NVIDIA Corporation, DEEP GENOMICS, Data4Cure, Inc., Freenome Holdings, Inc., Thermo Fisher Scientific, Illumina, Inc., SOPHiA GENETICS, BenevolentAI, Fabric Genomics |
| Key Drivers | • Pioneering Advances in Data Management and Drug Development |
| Restraints | • Unclear Regulatory Framework for Genomics Software • Shortage of Skilled Workforce and Infrastructure |
Ans: The Artificial Intelligence in Genomics market size was valued at US$ 726.9 Mn in 2023
Genome Sequencing, Gene Editing, Clinical Workflows, and Predictive Genetic Testing & Preventive Medicine are the sub segments of Artificial Intelligence in Genomics market.
Key drivers of the Artificial Intelligence in Genomics Market is Increasing the amount of money spent on AI in genomics, and AI is being more widely used in precision medicine
The use of artificial intelligence (AI) in genomics focuses on the development of computer systems that can perform tasks such as genome mapping. Furthermore, AI aids in the faster study of genetic material's structure, evolution, and function than is achievable with human interaction.
Ans: The Artificial Intelligence in Genomics Market is to grow at a CAGR of 46% during the forecast period 2024-2031
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Adoption Rates, 2023
5.2 User Demographics, By User Type and Roles, 2023
5.3 Feature Analysis, by Feature Type
5.4 Cost Analysis, by Software
5.5 Integration Capabilities
5.6 Regulatory Compliance, by Region
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Artificial Intelligence in Genomics Market Segmentation, by Component
7.1 Chapter Overview
7.2 Hardware
7.2.1 Hardware Market Trends Analysis (2020-2032)
7.2.2 Hardware Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Software
7.3.1 Software Market Trends Analysis (2020-2032)
7.3.2 Software Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Services
7.4.1 Services Market Trends Analysis (2020-2032)
7.4.2 Services Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Artificial Intelligence in Genomics Market Segmentation, By Technology
8.1 Chapter Overview
8.2 Machine Learning
8.2.1 Machine Learning Market Trends Analysis (2020-2032)
8.2.2 Machine Learning Market Size Estimates And Forecasts To 2032 (USD Billion)
8.2.3 Deep Learning
8.2.3.1 Deep Learning Market Trends Analysis (2020-2032)
8.2.3.2 Deep Learning Market Size Estimates And Forecasts To 2032 (USD Billion)
8.2.4 Supervised Learning
8.2.4.1 Supervised Learning Market Trends Analysis (2020-2032)
8.2.4.2 Supervised Learning Market Size Estimates And Forecasts To 2032 (USD Billion)
8.2.5 Unsupervised Learning
8.2.5.1 Unsupervised Learning Market Trends Analysis (2020-2032)
8.2.5.2 Unsupervised Learning Market Size Estimates And Forecasts To 2032 (USD Billion)
8.2.6 Others
8.2.6.1 Others Market Trends Analysis (2020-2032)
8.2.6.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
8.3 Computer Vision
8.3.1 Computer Vision Market Trends Analysis (2020-2032)
8.3.2 Computer Vision Market Size Estimates And Forecasts To 2032 (USD Billion)
9. Artificial Intelligence in Genomics Market Segmentation, By Functionality
9.1 Chapter Overview
9.2 Genome Sequencing
9.2.1 Genome Sequencing Market Trends Analysis (2020-2032)
9.2.2 Genome Sequencing Market Size Estimates And Forecasts To 2032 (USD Billion)
9.3 Gene Editing
9.3.1 Gene Editing Market Trends Analysis (2020-2032)
9.3.2 Gene Editing Market Size Estimates And Forecasts To 2032 (USD Billion)
9.4 Others
9.4.1 Others Market Trends Analysis (2020-2032)
9.4.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
10. Artificial Intelligence in Genomics Market Segmentation, By Application
10.1 Chapter Overview
10.2 Drug Discovery & Development
10.2.1 Drug Discovery & Development Market Trends Analysis (2020-2032)
10.2.2 Drug Discovery & Development Market Size Estimates And Forecasts To 2032 (USD Billion)
10.3 Precision Medicine
10.3.1 Precision Medicine Market Trends Analysis (2020-2032)
10.3.2 Precision Medicine Market Size Estimates And Forecasts To 2032 (USD Billion)
10.4 Diagnostics
10.4.1 Diagnostics Market Trends Analysis (2020-2032)
10.4.2 Diagnostics Market Size Estimates And Forecasts To 2032 (USD Billion)
10.5 Others
10.5.1 Others Market Trends Analysis (2020-2032)
10.5.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
11. Artificial Intelligence in Genomics Market Segmentation, By End-use
11.1 Chapter Overview
11.2 Pharmaceutical and Biotech Companies
11.2.1 Pharmaceutical and Biotech Companies Market Trends Analysis (2020-2032)
11.2.2 Pharmaceutical and Biotech Companies Market Size Estimates And Forecasts To 2032 (USD Billion)
11.3 Healthcare Providers
11.3.1 Healthcare Providers Market Trends Analysis (2020-2032)
11.3.2 Healthcare Providers Market Size Estimates And Forecasts To 2032 (USD Billion)
11.4 Research Centers
11.4.1 Research Centers Market Trends Analysis (2020-2032)
11.4.2 Research Centers Market Size Estimates And Forecasts To 2032 (USD Billion)
11.5 Others
11.5.1 Others Market Trends Analysis (2020-2032)
11.5.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
12. Regional Analysis
12.1 Chapter Overview
12.2 North America
12.2.1 Trends Analysis
12.2.2 North America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.2.3 North America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.2.4 North America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.2.5 North America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.2.6 North America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.2.7 North America Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.2.8 USA
12.2.8.1 USA Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.2.8.2 USA Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.2.8.3 USA Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.2.8.4 USA Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.2.8.5 USA Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.2.9 Canada
12.2.9.1 Canada Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.2.9.2 Canada Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.2.9.3 Canada Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.2.9.4 Canada Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.2.9.5 Canada Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.2.10 Mexico
12.2.10.1 Mexico Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.2.10.2 Mexico Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.2.10.3 Mexico Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.2.10.4 Mexico Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.2.10.5 Mexico Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3 Europe
12.3.1 Eastern Europe
12.3.1.1 Trends Analysis
12.3.1.2 Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.3.1.3 Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.1.4 Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.1.5 Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.1.6 Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.1.7 Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.1.8 Poland
12.3.1.8.1 Poland Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.1.8.2 Poland Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.1.8.3 Poland Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.1.8.4 Poland Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.1.8.5 Poland Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.1.9 Romania
12.3.1.9.1 Romania Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.1.9.2 Romania Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.1.9.3 Romania Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.1.9.4 Romania Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.1.9.5 Romania Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.1.10 Hungary
12.3.1.10.1 Hungary Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.1.10.2 Hungary Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.1.10.3 Hungary Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.1.10.4 Hungary Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.1.10.5 Hungary Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.1.11 Turkey
12.3.1.11.1 Turkey Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.1.11.2 Turkey Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.1.11.3 Turkey Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.1.11.4 Turkey Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.1.11.5 Turkey Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.1.12 Rest Of Eastern Europe
12.3.1.12.1 Rest Of Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.1.12.2 Rest Of Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.1.12.3 Rest Of Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.1.12.4 Rest Of Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.1.12.5 Rest Of Eastern Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2 Western Europe
12.3.2.1 Trends Analysis
12.3.2.2 Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.3.2.3 Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.2.4 Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.2.5 Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.6 Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.7 Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2.8 Germany
12.3.2.8.1 Germany Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.2.8.2 Germany Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.2.8.3 Germany Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.8.4 Germany Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.8.5 Germany Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2.9 France
12.3.2.9.1 France Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.2.9.2 France Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.2.9.3 France Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.9.4 France Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.9.5 France Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2.10 UK
12.3.2.10.1 UK Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.2.10.2 UK Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.2.10.3 UK Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.10.4 UK Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.10.5 UK Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2.11 Italy
12.3.2.11.1 Italy Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.2.11.2 Italy Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.2.11.3 Italy Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.11.4 Italy Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.11.5 Italy Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2.12 Spain
12.3.2.12.1 Spain Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.3.2.12.2 Spain Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.2.12.3 Spain Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.12.4 Spain Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.12.5 Spain Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2.13 Netherlands
12.3.2.13.1 Netherlands Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.3.2.13.2 Netherlands Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.3.2.13.3 Netherlands Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.13.4 Netherlands Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.13.5 Netherlands Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2.14 Switzerland
12.3.2.14.1 Switzerland Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.3.2.14.2 Switzerland Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.3.2.14.3 Switzerland Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.14.4 Switzerland Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.12.5 Switzerland Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2.15 Austria
12.3.2.15.1 Austria Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.3.2.15.2 Austria Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.3.2.15.3 Austria Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.15.4 Austria Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.15.5 Austria Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.3.2.16 Rest Of Western Europe
12.3.2.16.1 Rest Of Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.3.2.16.2 Rest Of Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.3.2.16.3 Rest Of Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.3.2.16.4 Rest Of Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.3.2.16.5 Rest Of Western Europe Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.4 Asia Pacific
12.4.1 Trends Analysis
12.4.2 Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.4.3 Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.4.4 Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.4.5 Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.4.6 Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.4.7 Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.4.8 China
12.4.8.1 China Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.4.8.2 China Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.4.8.3 China Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.4.8.4 China Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.4.8.5 China Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.4.9 India
12.4.9.1 India Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.4.9.2 India Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.4.9.3 India Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.4.9.4 India Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.4.9.5 India Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.4.10 Japan
12.4.10.1 Japan Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.4.10.2 Japan Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.4.10.3 Japan Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.4.10.4 Japan Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.4.10.5 Japan Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.4.11 South Korea
12.4.11.1 South Korea Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.4.11.2 South Korea Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.4.11.3 South Korea Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.4.11.4 South Korea Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.4.11.5 South Korea Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.4.12 Vietnam
12.4.12.1 Vietnam Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.4.12.2 Vietnam Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.4.12.3 Vietnam Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality(2020-2032) (USD Billion)
12.4.12.4 Vietnam Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.4.12.5 Vietnam Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.4.13 Singapore
12.4.13.1 Singapore Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.4.13.2 Singapore Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.4.13.3 Singapore Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.4.13.4 Singapore Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.4.13.5 Singapore Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.4.14 Australia
12.4.14.1 Australia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.4.14.2 Australia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.4.14.3 Australia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality(2020-2032) (USD Billion)
12.4.14.4 Australia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.4.14.5 Australia Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.4.15 Rest Of Asia Pacific
12.4.15.1 Rest Of Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.4.15.2 Rest Of Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology(2020-2032) (USD Billion)
12.4.15.3 Rest Of Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.4.15.4 Rest Of Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.4.15.5 Rest Of Asia Pacific Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5 Middle East And Africa
12.5.1 Middle East
12.5.1.1 Trends Analysis
12.5.1.2 Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.5.1.3 Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.5.1.4 Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.1.5 Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.5.1.6 Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.1.7 Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5.1.8 UAE
12.5.1.8.1 UAE Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.5.1.8.2 UAE Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.1.8.3 UAE Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.5.1.8.4 UAE Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.1.8.5 UAE Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5.1.9 Egypt
12.5.1.9.1 Egypt Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.5.1.9.2 Egypt Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.5.1.9.3 Egypt Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.5.1.9.4 Egypt Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.1.9.5 Egypt Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5.1.10 Saudi Arabia
12.5.1.10.1 Saudi Arabia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.5.1.10.2 Saudi Arabia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.5.1.10.3 Saudi Arabia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.5.1.10.4 Saudi Arabia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.1.10.5 Saudi Arabia Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5.1.11 Qatar
12.5.1.11.1 Qatar Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.5.1.11.2 Qatar Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.5.1.11.3 Qatar Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.5.1.11.4 Qatar Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.5.1.11.5 Qatar Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5.1.12 Rest Of Middle East
12.5.1.12.1 Rest Of Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.5.1.12.2 Rest Of Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.5.1.12.3 Rest Of Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.5.1.12.4 Rest Of Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.1.12.5 Rest Of Middle East Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5.2 Africa
12.5.2.1 Trends Analysis
12.5.2.2 Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.5.2.3 Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.5.2.4 Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.5.2.5 Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality(2020-2032) (USD Billion)
12.5.2.6 Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.2.7 Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5.2.8 South Africa
12.5.2.8.1 South Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.5.2.8.2 South Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.5.2.8.3 South Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.5.2.8.4 South Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.2.8.5 South Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5.2.9 Nigeria
12.5.2.9.1 Nigeria Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.5.2.9.2 Nigeria Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.5.2.9.3 Nigeria Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.5.2.9.4 Nigeria Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.5.2.9.5 Nigeria Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.5.2.10 Rest Of Africa
12.5.2.10.1 Rest Of Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.5.2.10.2 Rest Of Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.5.2.10.3 Rest Of Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.5.2.10.4 Rest Of Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.5.2.10.5 Rest Of Africa Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.6 Latin America
12.6.1 Trends Analysis
12.6.2 Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
12.6.3 Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.6.4 Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.6.5 Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.6.6 Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.6.7 Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.6.8 Brazil
12.6.8.1 Brazil Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.6.8.2 Brazil Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.6.8.3 Brazil Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.6.8.4 Brazil Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.6.8.5 Brazil Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.6.9 Argentina
12.6.9.1 Argentina Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.6.9.2 Argentina Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.6.9.3 Argentina Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.6.9.4 Argentina Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
12.6.9.5 Argentina Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.6.10 Colombia
12.6.10.1 Colombia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
12.6.10.2 Colombia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
12.6.10.3 Colombia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.6.10.4 Colombia Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.6.10.5 Colombia Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
12.6.11 Rest Of Latin America
12.6.11.1 Rest Of Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Component(2020-2032) (USD Billion)
12.6.11.2 Rest Of Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.6.11.3 Rest Of Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Functionality (2020-2032) (USD Billion)
12.6.11.4 Rest Of Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By Application(2020-2032) (USD Billion)
12.6.11.5 Rest Of Latin America Artificial Intelligence in Genomics Market Estimates And Forecasts, By End-use (2020-2032) (USD Billion)
13. Company Profiles
13.1 IBM
13.1.1 Company Overview
13.1.2 Financial
13.1.3 Products/ Services Offered
13.1.4 SWOT Analysis
13.2 Microsoft Corporation
13.2.1 Company Overview
13.2.2 Financial
13.2.3 Products/ Services Offered
13.2.4 SWOT Analysis
13.3 NVIDIA Corporation
13.3.1 Company Overview
13.3.2 Financial
13.3.3 Products/ Services Offered
13.3.4 SWOT Analysis
13.4 DEEP GENOMICS
13.4.1 Company Overview
13.4.2 Financial
13.4.3 Products/ Services Offered
13.4.4 SWOT Analysis
13.5 Data4Cure, Inc.
13.5.1 Company Overview
13.5.2 Financial
13.5.3 Products/ Services Offered
13.5.4 SWOT Analysis
13.6 Freenome Holdings, Inc.
13.6.1 Company Overview
13.6.2 Financial
13.6.3 Products/ Services Offered
13.6.4 SWOT Analysis
13.7 Thermo Fisher Scientific
13.7.1 Company Overview
13.7.2 Financial
13.7.3 Products/ Services Offered
13.7.4 SWOT Analysis
13.8 Illumina, Inc.
13.8.1 Company Overview
13.8.2 Financial
13.8.3 Products/ Services Offered
13.8.4 SWOT Analysis
13.9 SOPHiA GENETICS
13.9.1 Company Overview
13.9.2 Financial
13.9.3 Products/ Services Offered
13.9.4 SWOT Analysis
13.10 BenevolentAI
13.12.1 Company Overview
13.12.2 Financial
13.12.3 Products/ Services Offered
13.12.4 SWOT Analysis
14. Use Cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segmentation
By Component
Hardware
Software
Services
By Technology
Machine Learning
Deep Learning
Supervised Learning
Unsupervised Learning
Others
Computer Vision
By Functionality
Genome Sequencing
Gene Editing
Others
By Application
Drug Discovery & Development
Precision Medicine
Diagnostics
Others
By End-use
Pharmaceutical and Biotech Companies
Healthcare Providers
Research Centers
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Cystic Fibrosis Market size was valued at USD 6.02 billion in 2023, and is expected to reach USD 10.85 billion by 2032, and grow at a CAGR of 6.83% over the forecast period 2024-2032.
Artificial Cornea and Corneal Implant Market was valued at $ 0.47 Billion in 2023 and is expected to reach $ 0.97 Billion By 2032 and grow at a CAGR of 7.78%.
The High-Performance Liquid Chromatography Market size was valued at USD 4.8 billion in 2023 and is expected to grow to USD 7.83 billion by 2031 and grow at a CAGR of 6.30% over the forecast period of 2024-2031.
The Autoimmune Disease Testing Market size was valued at USD 11.24 billion in 2023 and it is expected to be worth around USD 24.14 billion by 2031 growing at a remarkable CAGR of 10.27% over the forecast period 2024-2031.
The Dental Imaging Market size was valued at US$ 3.08 billion in 2023 and is estimated to reach US$ 6.69 billion by 2032, with a growing CAGR of 9% over the forecast period 2024-2032.
The Oral Care Market Size was valued at USD 37.42 billion in 2023 and is expected to reach USD 67.05 billion by 2032, growing at a CAGR of 6.72% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
